Sameer K Berry1, Corey A Siegel2, Gil Y Melmed3,4. 1. Department of Medicine, Cedars-Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA, 90048, USA. 2. Department of Medicine, Dartmouth-Hitchcock Medical Center, 1 Medical Center Dr, Lebanon, NH, 03766, USA. 3. Department of Medicine, Cedars-Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA, 90048, USA. Gil.Melmed@cshs.org. 4. Inflammatory Bowel Disease Center, 8730 Alden Drive, Second Floor East, Los Angeles, CA, 90048, USA. Gil.Melmed@cshs.org.
Abstract
PURPOSE OF REVIEW: This article serves as an overview of several quality improvement initiatives in inflammatory bowel disease (IBD). RECENT FINDINGS: IBD is associated with significant variation in care, suggesting poor quality of care. There have been several efforts to improve the quality of care for patients with IBD. Quality improvement (QI) initiatives in IBD are intended to be patient-centric, improve outcomes for individuals and populations, and reduce costs-all consistent with "the triple aim" put forth by the Institute for Healthcare Improvement (IHI). Current QI initiatives include the development of quality measure sets to standardize processes and outcomes, learning health systems to foster collaborative improvement, and patient-centered medical homes specific to patients with IBD in shared risk models of care. Some of these programs have demonstrated early success in improving patient outcomes, reducing costs, improving patient satisfaction, and facilitating patient engagement. However, further studies are needed to evaluate and compare the effects of these programs over time on clinical outcomes in order to demonstrate long-term value and sustainability.
PURPOSE OF REVIEW: This article serves as an overview of several quality improvement initiatives in inflammatory bowel disease (IBD). RECENT FINDINGS: IBD is associated with significant variation in care, suggesting poor quality of care. There have been several efforts to improve the quality of care for patients with IBD. Quality improvement (QI) initiatives in IBD are intended to be patient-centric, improve outcomes for individuals and populations, and reduce costs-all consistent with "the triple aim" put forth by the Institute for Healthcare Improvement (IHI). Current QI initiatives include the development of quality measure sets to standardize processes and outcomes, learning health systems to foster collaborative improvement, and patient-centered medical homes specific to patients with IBD in shared risk models of care. Some of these programs have demonstrated early success in improving patient outcomes, reducing costs, improving patient satisfaction, and facilitating patient engagement. However, further studies are needed to evaluate and compare the effects of these programs over time on clinical outcomes in order to demonstrate long-term value and sustainability.
Entities:
Keywords:
Gastroenterology; Inflammatory bowel disease; Learning health system; Quality improvement; Quality measures; Specialty medical home
Authors: Gilaad G Kaplan; Ellen P McCarthy; John Z Ayanian; Joshua Korzenik; Richard Hodin; Bruce E Sands Journal: Gastroenterology Date: 2008-01-10 Impact factor: 22.682
Authors: Geoffrey C Nguyen; Shane M Devlin; Waqqas Afif; Brian Bressler; Steven E Gruchy; Gilaad G Kaplan; Liliana Oliveira; Sophie Plamondon; Cynthia H Seow; Chadwick Williams; Karen Wong; Brian M Yan; Jennifer Jones Journal: Can J Gastroenterol Hepatol Date: 2014-05
Authors: Wallace Crandall; Michael D Kappelman; Richard B Colletti; Ian Leibowitz; John E Grunow; Sabina Ali; Howard I Baron; James H Berman; Brendan Boyle; Stanley Cohen; Fernando del Rosario; Lee A Denson; Lynn Duffy; Mark J Integlia; Sandra C Kim; David Milov; Ashish S Patel; Bess T Schoen; Dorota Walkiewicz; Peter Margolis Journal: Inflamm Bowel Dis Date: 2011-01 Impact factor: 5.325
Authors: Gil Y Melmed; Corey Allan Siegel; Brennan M Spiegel; John I Allen; Robert Cima; Jean-Frederic Colombel; Themistocles Dassopoulos; Lee A Denson; Sharon Dudley-Brown; Andrew Garb; Stephen B Hanauer; Michael D Kappelman; James D Lewis; Isabelle Lynch; Amy Moynihan; David T Rubin; R Balfour Sartor; Ronald M Schwartz; Douglas C Wolf; Thomas A Ullman Journal: Inflamm Bowel Dis Date: 2013-03 Impact factor: 5.325
Authors: Brennan M R Spiegel; Wayne Ho; Eric Esrailian; Stephan Targan; Peter D R Higgins; Corey A Siegel; Marla Dubinsky; Gil Y Melmed Journal: Clin Gastroenterol Hepatol Date: 2008-09-04 Impact factor: 11.382
Authors: Kimberly N Weaver; Michael D Kappelman; Robert S Sandler; Christopher F Martin; Wenli Chen; Kristen Anton; Millie D Long Journal: Inflamm Bowel Dis Date: 2016-11 Impact factor: 5.325
Authors: Miguel D Regueiro; Sandra E McAnallen; Julia B Greer; Stephen E Perkins; S Ramalingam; Eva Szigethy Journal: Inflamm Bowel Dis Date: 2016-08 Impact factor: 5.325
Authors: Andrea Altschuler; Bernadette Collins; James D Lewis; Fernando Velayos; James E Allison; Susan Hutfless; Liyan Liu; Lisa J Herrinton Journal: Inflamm Bowel Dis Date: 2008-07 Impact factor: 5.325
Authors: Shirley Cohen-Mekelburg; Sameer Berry; Ryan W Stidham; Ji Zhu; Akbar K Waljee Journal: J Gastroenterol Hepatol Date: 2021-02 Impact factor: 4.029